Jason Drew Smith - 30 Nov 2021 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
General Counsel
Signature
/s/ Jason Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
30 Nov 2021
Net transactions value
-$45,750
Form type
4
Filing time
02 Dec 2021, 12:16:10 UTC
Previous filing
08 Jun 2021
Next filing
02 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise +8,333 +333% 10,833 30 Nov 2021 Direct F1
transaction URGN Ordinary Shares Sale $45,750 -3,803 -35% $12.03 7,030 30 Nov 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Restricted Stock Units Options Exercise $0 -8,333 -33% $0.000000 16,667 30 Nov 2021 Ordinary Shares 8,333 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer
F2 Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units
F3 1/3 of the shares underlying the restricted stock units will vest on each of November 30, 2021, August 31, 2022 and August 31, 2023.